Clinical Trial Update: A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 pharmacokinetics study of PF-07923568 in individuals with renal impairment to assess how loss of kidney function affects drug process…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• PF-07923568

Snippet

Sponsor: Pfizer | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED